Your browser doesn't support javascript.
loading
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.
Bailón, Lucia; Llano, Anuska; Cedeño, Samandhy; Escribà, Tuixent; Rosás-Umbert, Miriam; Parera, Mariona; Casadellà, Maria; Lopez, Miriam; Pérez, Francisco; Oriol-Tordera, Bruna; Ruiz-Riol, Marta; Coll, Josep; Perez, Felix; Rivero, Àngel; Leselbaum, Anne R; McGowan, Ian; Sengupta, Devi; Wee, Edmund G; Hanke, Tomás; Paredes, Roger; Alarcón-Soto, Yovaninna; Clotet, Bonaventura; Noguera-Julian, Marc; Brander, Christian; Molto, Jose; Mothe, Beatriz.
Affiliation
  • Bailón L; Fundació Lluita Contra les Infeccions, Infectious Diseases Department, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.
  • Llano A; Department of Medicine, Autonomous University of Barcelona, Catalonia, Spain.
  • Cedeño S; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.
  • Escribà T; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.
  • Rosás-Umbert M; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.
  • Parera M; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.
  • Casadellà M; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Lopez M; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.
  • Pérez F; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.
  • Oriol-Tordera B; Fundació Lluita Contra les Infeccions, Infectious Diseases Department, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.
  • Ruiz-Riol M; Fundació Lluita Contra les Infeccions, Infectious Diseases Department, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.
  • Coll J; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.
  • Perez F; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.
  • Rivero À; CIBERINFEC, ISCIII, Madrid, Spain.
  • Leselbaum AR; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.
  • McGowan I; CIBERINFEC, ISCIII, Madrid, Spain.
  • Sengupta D; Projecte Dels Noms-Hispanosida, Bcn Checkpoint, Barcelona, Spain.
  • Wee EG; Projecte Dels Noms-Hispanosida, Bcn Checkpoint, Barcelona, Spain.
  • Hanke T; Projecte Dels Noms-Hispanosida, Bcn Checkpoint, Barcelona, Spain.
  • Paredes R; Projecte Dels Noms-Hispanosida, Bcn Checkpoint, Barcelona, Spain.
  • Alarcón-Soto Y; AELIX Therapeutics S.L, Barcelona, Spain.
  • Clotet B; University of Pittsburgh, Pittsburgh, PA, USA.
  • Noguera-Julian M; Gilead Sciences, Inc, Foster City, CA, USA.
  • Brander C; The Jenner Institute, The Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Molto J; The Jenner Institute, The Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Mothe B; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Nat Med ; 28(12): 2611-2621, 2022 12.
Article in En | MEDLINE | ID: mdl-36302893

Full text: 1 Database: MEDLINE Main subject: Vaccines / HIV Infections / HIV-1 / AIDS Vaccines Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2022 Type: Article Affiliation country: Spain

Full text: 1 Database: MEDLINE Main subject: Vaccines / HIV Infections / HIV-1 / AIDS Vaccines Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2022 Type: Article Affiliation country: Spain